Andy Lundin, Author at Advanced Oncology

The Role of Mass Spectrometry in Cancer Biomarker Discovery

Mass spectrometry is revolutionizing cancer biomarker discovery, enhancing early detection and personalized treatment.

Posted by Andy Lundin | Jun 1, 2024 | Lab Equipment |

Advanced genomic sequencing tech is revolutionizing cancer research by enabling the identification of genetic mutations and biomarkers.

Smart beds are revolutionizing patient comfort in oncology wards, enhancing safety, monitoring, and overall patient care.

Posted by Andy Lundin | Jun 1, 2024 | OR Technology |

AI and machine learning are revolutionizing surgical navigation systems, bringing unprecedented precision to surgical procedures.

Posted by Andy Lundin | Jun 1, 2024 | Pharmacogenomics |

Pharmacogenomics is transforming pediatric oncology by tailoring treatments to individual genetic profiles.